Oral slow release preparation, entrapment material and preparation method

A technology for encapsulating materials and slow-release drugs, which can be used in pharmaceutical formulations, medical preparations without active ingredients, and medical preparations containing active ingredients, etc. It can solve problems such as short duration of action, improve compliance, prolong Action time, high biocompatibility effect

Inactive Publication Date: 2012-09-12
CHINA PHARM UNIV
View PDF6 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] The object of the present invention is to provide a protein polypeptide oral sustained-release preparation, and a packaging material used for encapsulating protein polypeptide drugs, so as to solve the p

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Oral slow release preparation, entrapment material and preparation method
  • Oral slow release preparation, entrapment material and preparation method
  • Oral slow release preparation, entrapment material and preparation method

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0041] Example one

[0042] Weigh exenatide 5mg, sodium alginate: sodium hyaluronate = 2:3, dissolve the mixture of exenatide, sodium alginate and sodium hyaluronate in three-distilled water with a concentration of 25 mg / ml, stir and dissolve Obtain the water phase, add 2% Span-80 to 20ml of liquid paraffin to obtain the oil phase, add the water phase dropwise to the oil phase, magnetically stir at 500rpm / min to make the water phase uniformly dispersed in the oil phase; add to the oil phase 2ml 25% glutaraldehyde solution and 10ml 1M dilute hydrochloric acid, react at 20℃; after the reaction, add 20ml ethanol, stir at room temperature for 15 minutes, let stand for layering, discard the upper layer, filter the lower layer and wash it several times with ethanol. Preparation is complete after freeze-drying. Weigh 100mg of the drug-loaded Exenatide microspheres and 100mg of the blank microspheres prepared under the same conditions, and place them in a 20ml system to determine the en...

Example Embodiment

[0043] Example two

[0044] Weigh exenatide 10mg, sodium alginate: sodium hyaluronate=1:1, dissolve the mixture of exenatide, sodium alginate and sodium hyaluronate in three-distilled water to a concentration of 20mg / ml, stir and dissolve Obtain the water phase, add 1% Span-80 to 50ml of liquid paraffin to obtain the oil phase, add the water phase dropwise to the oil phase, magnetically stir at 700rpm / min to make the water phase uniformly dispersed in the oil phase; add to the oil phase 20ml 25% glutaraldehyde solution and 10ml 1M dilute hydrochloric acid, react at 50℃; after the reaction, add 20ml absolute ethanol, stir at room temperature for 15 minutes, let stand for layering, discard the upper layer, filter the lower layer and wash with ethanol. The preparation is complete after freeze-drying. The encapsulation rate of Exenatide microspheres determined by BCA method is 78%, and the particle size <200μm.

Example Embodiment

[0045] Example three

[0046] Weigh exenatide 10mg, sodium alginate: sodium hyaluronate=1:3, dissolve the mixture of exenatide, sodium alginate and sodium hyaluronate in three-distilled water, the concentration is 40mg / ml, stir to dissolve Obtain the water phase, add 1% Span-80 to 20ml of liquid paraffin to obtain the oil phase, add the water phase dropwise to the oil phase, magnetically stir at 500rpm / min to make the water phase uniformly dispersed in the oil phase; add to the oil phase 5ml 25% glutaraldehyde solution and 5ml 1M dilute hydrochloric acid, react at 25℃, add 20ml ethanol after the reaction, stir at room temperature for 15 minutes, let stand for layering, discard the upper layer, filter the lower layer and wash it several times with ethanol, freeze After drying, the preparation is complete. The encapsulation rate of Exenatide microspheres determined by BCA method is 86%, and the particle size is <220μm.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
The average particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention discloses an oral slow release preparation, an entrapment material and a preparation method. A sodium alginate-sodium hyaluronate mixture is taken as an entrapment material; and a prepared protein polypeptide medicament oral slow release preparation consists of the following components in percentage by mass: 0.5-10 percent of medicament and 90-99.5 percent of sodium alginate-sodium hyaluronate mixture. According to the oral slow release preparation, the conventional administration way of a protein polypeptide medicament is changed, the acting time of the protein polypeptide medicament is prolonged, the normal blood sugar level is maintained successfully for 12 hours when exenatide oral microspheres are taken as an example, the administration compliance of a diabetes patient is improved remarkably, and the treatment effect is enhanced.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations and relates to the preparation of oral sustained-release preparations, in particular to oral sustained-release preparations of protein and polypeptide drugs with a sodium alginate-sodium hyaluronate combination as a carrier and its preparation and application. Background technique [0002] With the development of biotechnology and genetic engineering, the use of protein and polypeptide drugs in clinical treatment is on the rise, but complex preparation processes, low delivery efficiency, and poor bioavailability have become bottlenecks in the clinical application of protein and polypeptide drugs. Among them, the route of administration of protein and polypeptide drugs is particularly important. Compared with injection preparations, oral preparations have better patient compliance and are more convenient to take, but the research on oral preparations of protein and polypeptide drugs is mo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K47/48A61K38/00A61K38/22A61P3/10
Inventor 陈依军范宇刘楠
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap